We are live on
!
Find out more
IACGFIA
IDG-Accel China Growth Fund III Associates Portfolio holdings
AUM
$31.2M
1-Year Est. Return
2.97%
This Fund
S&P 500
This Quarter
Est. Return
-19.91%
1 Year Est. Return
-2.97%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$55M
AUM Growth
-$19.2M
(-26%)
Cap. Flow
-$3.89M
Cap. Flow
% of AUM
-7.08%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AIH
Aesthetic Medical International Holdings
AIH
|
+$3.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.69% |
| 2 | Healthcare | 28.45% |
| 3 | Consumer Discretionary | 25.1% |
| 4 | Consumer Staples | 7.76% |
Similar funds
GII
PC
TK
SA
SGAM
MCP
OEP
EIP
IDG-Accel China Growth Fund III Associates's Q2 2021 Portfolio in Review
As of Q2 2021, IDG-Accel China Growth Fund III Associates held 6 positions worth $55M, down 26% from $74.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
IDG-Accel China Growth Fund III Associates withdrew a net $3.89M in Q2 2021, reducing 1 holding. Its largest reduction was Aesthetic Medical International Holdings, cutting an estimated $3.89M.
By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 37% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- IDG-Accel China Growth Fund III Associates's biggest Q2 2021 reduction was Aesthetic Medical International Holdings, cutting an estimated $3.89M.
- IDG-Accel China Growth Fund III Associates's ten largest holdings make up 100% of its $55M portfolio in Q2 2021.
- IDG-Accel China Growth Fund III Associates opened 0 new positions and closed 0 in Q2 2021.
- IDG-Accel China Growth Fund III Associates's portfolio value fell 26% quarter-over-quarter to $55M.
Based on IDG-Accel China Growth Fund III Associates's 13F filing for Q2 2021, filed 16 Aug 2021.